Link Technologies Limited, a leading manufacturer of oligonucleotide synthesis reagents, has appointed former President of Avecia Biotechnology Inc, Dr Michael McLean, as Chairman to lead them through an exciting period of change and expansion.
Link Technologies Limited, a leading manufacturer of oligonucleotide synthesis reagents, has appointed former President of Avecia Biotechnology Inc, Dr Michael McLean, as Chairman to lead them through an exciting period of change and expansion.